Ambeed.cn

首页 / / / PI3K / A66

A66 {[allProObj[0].p_purity_real_show]}

货号:A102947 Ambeed 开学季,买赠积分,赢豪礼

A66 is a potent and specific p110α inhibitor with IC50 of 32 nM, > 100 fold selectivity for p110α over other class-I PI3K isoforms.

A66 化学结构 CAS号:1166227-08-2
A66 化学结构
CAS号:1166227-08-2
A66 3D分子结构
CAS号:1166227-08-2
A66 化学结构 CAS号:1166227-08-2
A66 3D分子结构 CAS号:1166227-08-2
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

A66 纯度/质量文件 产品仅供科研

货号:A102947 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

JACS Au, 2024. Ambeed. [ A148168 ]
JMC, 2024. Ambeed. [ A187643 ]
JMC, 2024. Ambeed. [ A341145 , A633512 , A607865 , A167774 ]
Biomacromolecules, 2024. Ambeed. [ A110759 ]
Biomacromolecules, 2024. Ambeed. [ A203543 ]
更多 >
产品名称 C2β p110α p110β p110γ p110δ PI3K Vps34 其他靶点 纯度
A66 +

C2β, IC50: 462 nM

++

p110α, IC50: 32 nM

{[allProObj[0].p_purity_real_show]}
Taselisib +

C2β, IC50: 292 nM

++++

PI3Kα, Ki: 0.29 nM

+++

PI3Kβ, Ki: 9.1 nM

++++

PI3Kγ, Ki: 0.97 nM

++++

PI3Kδ, Ki: 0.12 nM

+

hVps34, IC50: 374 nM

{[allProObj[0].p_purity_real_show]}
Gedatolisib ++++

PI3Kα, IC50: 0.4 nM

+++

PI3Kγ, IC50: 5.4 nM

mTOR {[allProObj[0].p_purity_real_show]}
HS-173 ++++

PI3Kα , IC50: 0.8 nM

{[allProObj[0].p_purity_real_show]}
Serabelisib +++

PI3Kα, IC50: 21 nM

{[allProObj[0].p_purity_real_show]}
GNE-477 ++++

PI3Kα, IC50: 4 nM

mTOR {[allProObj[0].p_purity_real_show]}
YM-201636 +

p110α, IC50: 3.3 μM

PIKfyve {[allProObj[0].p_purity_real_show]}
AS-252424 +

PI3Kα, IC50: 935 nM

++

PI3Kγ, IC50: 33 nM

{[allProObj[0].p_purity_real_show]}
Alpelisib +++

PI3Kα, IC50: 5 nM

{[allProObj[0].p_purity_real_show]}
AS-604850 +

PI3Kα, IC50: 4.5 μM

+

PI3Kγ, IC50: 0.25 μM

{[allProObj[0].p_purity_real_show]}
SF2523 ++

PI3Kα, IC50: 34 nM

++

PI3Kγ, IC50: 158 nM

mTOR,DNA-PK {[allProObj[0].p_purity_real_show]}
Inavolisib ++++

PI3K alpha, IC50: 0.038 nM

{[allProObj[0].p_purity_real_show]}
Bimiralisib ++++

PI3Kα, Kd: 1.5 nM

+++

PI3Kβ, Kd: 11 nM

++

PI3Kγ, Kd: 25 nM

++

PI3Kδ, Kd: 25 nM

mTOR {[allProObj[0].p_purity_real_show]}
GSK1059615 ++++

PI3Kα, IC50: 0.4 nM

++++

PI3Kβ, IC50: 0.6 nM

+++

PI3Kγ, IC50: 5 nM

++++

PI3Kδ, IC50: 2 nM

mTOR {[allProObj[0].p_purity_real_show]}
GSK2636771 {[allProObj[0].p_purity_real_show]}
Fimepinostat +++

PI3Kα, IC50: 19 nM

++

PI3Kβ, IC50: 54 nM

++

PI3Kδ, IC50: 39 nM

{[allProObj[0].p_purity_real_show]}
VS-5584 ++++

PI3Kα, IC50: 2.6 nM

+++

PI3Kβ, IC50: 21 nM

++++

PI3Kγ, IC50: 3.0 nM

++++

PI3Kδ, IC50: 2.7 nM

mTOR {[allProObj[0].p_purity_real_show]}
Dactolisib ++++

p110α1, IC50: 4 nM

++

p110β, IC50: 75 nM

+++

p110γ, IC50: 5 nM

+++

p110δ, IC50: 7 nM

{[allProObj[0].p_purity_real_show]}
PI-103 ++++

p110α, IC50: 2 nM

++++

p110β, IC50: 3 nM

+++

p110γ, IC50: 15 nM

++++

p110δ, IC50: 3 nM

mTOR,DNA-PK {[allProObj[0].p_purity_real_show]}
PI-3065 +

p110β, IC50: 1078 nM

+++

p110δ, IC50: 15 nM

{[allProObj[0].p_purity_real_show]}
Voxtalisib ++

PI3Kα, IC50: 39 nM

++

PI3Kβ, IC50: 113 nM

+++

PI3Kγ, IC50: 9 nM

++

PI3Kδ, IC50: 43 nM

mTOR,DNA-PK {[allProObj[0].p_purity_real_show]}
AZD-8835 +++

PI3Kα, IC50: 6.2 nM

+

PI3Kβ, IC50: 431 nM

++

PI3Kγ, IC50: 90 nM

+++

PI3Kδ, IC50: 5.7 nM

{[allProObj[0].p_purity_real_show]}
Pilaralisib analogue ++

PI3Kα, IC50: 39 nM

++

PI3Kβ, IC50: 36 nM

+++

PI3Kγ, IC50: 23 nM

++

PI3Kδ, IC50: 36 nM

{[allProObj[0].p_purity_real_show]}
ZSTK474 +++

PI3Kα, IC50: 16 nM

++

PI3Kβ, IC50: 44 nM

++

PI3Kγ, IC50: 49 nM

+++

PI3Kδ, IC50: 4.6 nM

++

PI3K, IC50: 37 nM

{[allProObj[0].p_purity_real_show]}
AS-605240 ++

PI3Kα, IC50: 60 nM

+

PI3Kβ, IC50: 270 nM

+++

PI3Kγ, IC50: 8 nM

+

PI3Kδ, IC50: 300 nM

{[allProObj[0].p_purity_real_show]}
TGX-221 +++

p110β, IC50: 5 nM

++

p110δ, IC50: 0.1 μM

{[allProObj[0].p_purity_real_show]}
PF-04691502 ++++

PI3Kα, Ki: 1.8 nM

++++

PI3Kβ, Ki: 2.1 nM

++++

PI3Kγ, Ki: 1.9 nM

++++

PI3Kδ, Ki: 1.6 nM

mTOR {[allProObj[0].p_purity_real_show]}
GDC-0084 ++++

PI3Kα, Ki app: 2 nM

++

PI3Kβ, Ki app: 46 nM

+++

PI3Kγ, Ki app: 10 nM

++++

PI3Kδ, Ki app: 3 nM

mTOR {[allProObj[0].p_purity_real_show]}
Buparlisib ++

p110α, IC50: 52 nM

+

p110β, IC50: 166 nM

+

p110γ, IC50: 262 nM

++

p110δ, IC50: 116 nM

+

Vps34, IC50: 2.4 μM

mTOR {[allProObj[0].p_purity_real_show]}
LY294002 +

p110α, IC50: 0.5 μM

+

p110β, IC50: 0.97 μM

+

p110δ, IC50: 0.57 μM

DNA-PK {[allProObj[0].p_purity_real_show]}
AZD 6482 +

PI3Kα, IC50: 870 nM

+++

PI3Kβ, IC50: 10 nM

++

PI3Kδ, IC50: 80 nM

DNA-PK {[allProObj[0].p_purity_real_show]}
Pictilisib ++++

p110α, IC50: 3 nM

++

p110β, IC50: 33 nM

++

p110γ, IC50: 75 nM

++++

p110δ, IC50: 3 nM

mTOR {[allProObj[0].p_purity_real_show]}
PKI-402 ++++

PI3Kα, IC50: 2 nM

+++

PI3Kβ, IC50: 7 nM

+++

PI3Kγ, IC50: 16 nM

+++

PI3Kδ, IC50: 14 nM

mTOR {[allProObj[0].p_purity_real_show]}
Copanlisib ++++

PI3Kα, IC50: 0.5 nM

++++

PI3Kβ, IC50: 3.7 nM

+++

PI3Kγ, IC50: 6.4 nM

++++

PI3Kδ, IC50: 0.7 nM

{[allProObj[0].p_purity_real_show]}
Omipalisib ++++

p110α, Ki: 0.019 nM

++++

p110β, Ki: 0.13 nM

++++

p110γ, Ki: 0.06 nM

++++

p110δ, Ki: 0.024 nM

{[allProObj[0].p_purity_real_show]}
Izorlisib +++

PI3Kα, IC50: 14 nM

++

PI3Kβ, IC50: 0.12 μM

++

PI3Kγ, IC50: 36 nM

+

PI3Kδ, IC50: 0.50 μM

{[allProObj[0].p_purity_real_show]}
AZD8186 ++

PI3Kα, IC50: 35 nM

++++

PI3Kβ, IC50: 4 nM

+++

PI3Kδ, IC50: 12 nM

{[allProObj[0].p_purity_real_show]}
KU-0060648 ++++

PI3Kα, IC50: 4 nM

++++

PI3Kβ, IC50: 0.5 nM

+

PI3Kγ, IC50: 0.59 μM

++++

PI3Kδ, IC50: 0.1 nM

DNA-PK {[allProObj[0].p_purity_real_show]}
Apitolisib +++

p110α, IC50: 5 nM

++

p110β, IC50: 27 nM

+++

p110γ, IC50: 14 nM

+++

p110δ, IC50: 7 nM

mTOR {[allProObj[0].p_purity_real_show]}
CZC24832 +

PI3Kβ, IC50: 1.1 μM

++

PI3Kγ, IC50: 27 nM

{[allProObj[0].p_purity_real_show]}
BGT226 maleate ++++

PI3Kα, IC50: 4 nM

++

PI3Kβ, IC50: 63 nM

++

PI3Kγ, IC50: 38 nM

mTOR {[allProObj[0].p_purity_real_show]}
TG 100713 ++

PI3Kα, IC50: 165 nM

+

PI3Kβ, IC50: 215 nM

++

PI3Kγ, IC50: 50 nM

+++

PI3Kδ, IC50: 24 nM

{[allProObj[0].p_purity_real_show]}
PI3K-IN-1 ++

PI3Kα, IC50: 39 nM

++

PI3Kβ, IC50: 113 nM

+++

PI3Kγ, IC50: 9 nM

++

PI3Kδ, IC50: 43 nM

mTOR,DNA-PK {[allProObj[0].p_purity_real_show]}
TG100-115 +

PI3Kα, IC50: 1.3 μM

+

PI3Kβ, IC50: 1.2 μM

++

PI3Kγ, IC50: 83 nM

+

PI3Kδ, IC50: 235 nM

{[allProObj[0].p_purity_real_show]}
PIK-90 +++

PI3Kα, IC50: 11 nM

+

PI3Kβ, IC50: 350 nM

+++

PI3Kγ, IC50: 18 nM

++

PI3Kδ, IC50: 58 nM

{[allProObj[0].p_purity_real_show]}
PIK-294 +

p110β, IC50: 490 nM

++

p110γ, IC50: 160 nM

+++

p110δ, IC50: 10 nM

{[allProObj[0].p_purity_real_show]}
Duvelisib ++++

PI3Kβ, Ki: 1564 pM

++

PI3Kγ, Ki: 243 pM

++++

PI3Kδ, Ki: 23 pM

{[allProObj[0].p_purity_real_show]}
GDC-0326 ++++

PI3Kα, Ki: 0.2 nM

++

PI3Kβ, Ki: 26.6 nM

+++

PI3Kγ, Ki: 10.2 nM

++++

PI3Kδ, Ki: 4 nM

{[allProObj[0].p_purity_real_show]}
Quercetin Dihydrate +

PI3Kβ, IC50: 5.4 μM

+

PI3Kγ, IC50: 2.4 μM

+

PI3Kδ, IC50: 3.0 μM

{[allProObj[0].p_purity_real_show]}
Quercetin +

PI3Kβ, IC50: 5.4 μM

+

PI3Kγ, IC50: 2.4 μM

+

PI3Kδ, IC50: 3.0 μM

PKC,Sirtuin,Src {[allProObj[0].p_purity_real_show]}
Leniolisib +

PI3Kα, IC50: 0.244 μM

+

PI3Kβ, IC50: 0.424 μM

+

PI3Kγ, IC50: 2.23 μM

+++

PI3Kδ, IC50: 0.011 μM

DNA-PK {[allProObj[0].p_purity_real_show]}
PIK-108 {[allProObj[0].p_purity_real_show]}
Eganelisib +++

PI3Kγ, IC50: 16 nM

{[allProObj[0].p_purity_real_show]}
CAY10505 {[allProObj[0].p_purity_real_show]}
IPI-3063 ++++

p110δ, IC50: 2.5 nM

{[allProObj[0].p_purity_real_show]}
Nemiralisib ++++

PI3Kδ, pKi: 9.9

{[allProObj[0].p_purity_real_show]}
PF-4989216 ++++

p110α, IC50: 2 nM

++

p110γ, IC50: 65 nM

++++

p110δ, IC50: 1 nM

{[allProObj[0].p_purity_real_show]}
PIK-75 HCl +++

p110α, IC50: 5.8 nM

++

p110γ, IC50: 76 nM

+

p110δ, IC50: 0.51 μM

DNA-PK {[allProObj[0].p_purity_real_show]}
Tenalisib ++

PI3Kγ, IC50: 33.2 nM

++

PI3Kδ, IC50: 24.5 nM

{[allProObj[0].p_purity_real_show]}
Acalisib +++

p110δ, IC50: 14 nM

{[allProObj[0].p_purity_real_show]}
Umbralisib +++

PI3Kδ, IC50: 22.2 nM

{[allProObj[0].p_purity_real_show]}
AMG319 +

PI3Kγ, IC50: 850 nM

+++

PI3Kδ, IC50: 18 nM

{[allProObj[0].p_purity_real_show]}
IC-87114 +

PI3Kγ, IC50: 29 μM

+

PI3Kδ, IC50: 0.5 μM

{[allProObj[0].p_purity_real_show]}
Idelalisib ++

p110γ, IC50: 89 nM

++++

p110δ, IC50: 2.5 nM

{[allProObj[0].p_purity_real_show]}
PIK-293 +

p110γ, IC50: 10 μM

+

p110δ, IC50: 0.24 μM

{[allProObj[0].p_purity_real_show]}
Vps34-PIK-III +

PI3Kδ, IC50: 1.2μM

+++

Vps34, IC50: 0.018μM

{[allProObj[0].p_purity_real_show]}
GSK2292767 {[allProObj[0].p_purity_real_show]}
Seletalisib +

PI3Kγ, IC50: 282 nM

+++

PI3Kδ, IC50: 12 nM

{[allProObj[0].p_purity_real_show]}
P110δ-IN-1 ++++

P110δ, IC50: 0.6 nM

{[allProObj[0].p_purity_real_show]}
PI3Kδ-IN-5 ++++

PI3Kδ, IC50: 0.9 nM

{[allProObj[0].p_purity_real_show]}
SRX3207 +

PI3K alpha, IC50: 244 nM

+

PI3K gamma, IC50: 9790 nM

+

PI3K delta, IC50: 388 nM

Syk {[allProObj[0].p_purity_real_show]}
Parsaclisib HCl ++++

PI3Kδ, IC50: 1 nM

{[allProObj[0].p_purity_real_show]}
IHMT-PI3Kδ-372 +++

PI3Kδ, IC50: 14 nM

{[allProObj[0].p_purity_real_show]}
Trigonelline Akt {[allProObj[0].p_purity_real_show]}
Wortmannin ++++

PI3K, IC50: 3 nM

DNA-PK,MLCK {[allProObj[0].p_purity_real_show]}
Samotolisib DNA-PK {[allProObj[0].p_purity_real_show]}
GNE-317 {[allProObj[0].p_purity_real_show]}
Oroxin B Akt,PTEN {[allProObj[0].p_purity_real_show]}
NU 7026 +

PI3K, IC50: 13 μM

DNA-PK {[allProObj[0].p_purity_real_show]}
Deguelin Akt {[allProObj[0].p_purity_real_show]}
Ailanthone Akt,CDK,ATM/ATR {[allProObj[0].p_purity_real_show]}
Resibufogenin ROS {[allProObj[0].p_purity_real_show]}
KU-57788 +

PI3K, IC50: 5 μM

mTOR,DNA-PK {[allProObj[0].p_purity_real_show]}
Cinobufagine Akt {[allProObj[0].p_purity_real_show]}
α-Linolenic acid {[allProObj[0].p_purity_real_show]}
MTX-211 EGFR {[allProObj[0].p_purity_real_show]}
PI3K/mTOR Inhibitor-2 ++++

PI3K, IC50: 3.4 nM

mTOR {[allProObj[0].p_purity_real_show]}
SPP-86 {[allProObj[0].p_purity_real_show]}
(E)-Akt inhibitor-IV {[allProObj[0].p_purity_real_show]}
Vps34-IN-1 ++

Vps34, IC50: 25 nM

{[allProObj[0].p_purity_real_show]}
SAR405 ++++

Vps34, IC50: 1.2 nM

{[allProObj[0].p_purity_real_show]}
3-Methyladenine +

PI3Kγ, IC50: 60 μM

+

Vps34, IC50: 25 μM

Autophagy {[allProObj[0].p_purity_real_show]}
Vps34-IN-4 +++

VPS34, IC50: 15 nM

{[allProObj[0].p_purity_real_show]}
Autophinib +++

Vps34, IC50: 19 nM

Autophagy {[allProObj[0].p_purity_real_show]}
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

A66 生物活性

靶点
  • C2β

    C2β, IC50:462 nM

  • p110α

    p110α, IC50:32 nM

描述 The three class-Ia PI3Ks (phosphoinositide 3-kinases; p110α/p110β/p110δ) and the sole class-Ib PI3K (p110γ) couple growth factor receptors and G-protein-coupled receptors to a wide range of downstream pathways, they all use PtdIns(4,5)P2 to produce PtdIns(3,4,5)P3. The cellular levels of PtdIns(3,4,5)P3 are tightly controlled by phosphatases, including PTEN (phosphatase and tensin homologue deleted on chromosome 10) which dephosphorylates PtdIns(3,4,5)P3 back to PtdIns(4,5) P2. The importance of this pathway in cancer is highlighted by the fact that defects in both the kinase and phosphatase activities are commonly observed in tumours. A66 is a highly selective and specific p110α inhibitor with IC50 value of 32 nM in the cell-free assay. The effect of the A66 S form was tested on SK-OV-3 tumour tissue in vivo using a single dose of 100 mg/kg of body weight to determine whether a long-lasting effect of the drug could be achieved on target tissues. A66 S caused a profound reduction in the phosphorylation of Akt/PKB and p70 S6 kinase at both 1 and 6 h after dosing. This is consistent with A66 S having a full inhibitory effect on PI3K signalling in the tumours during this time. A66 S was dosed QD at 100 mg/kg of body weight for up to 21 days or BID at 75 mg/kg of body weight for 16 days in tumour efficacy studies. Both dosing strategies induced a significant delay in growth of SK-OV-3 xenografted tumours. At the final day of dosing, the average TGI (tumour growth inhibition) for A66 S form was 45.9% of control (QD; P<0.05) and 29.9% of control (BID; P<0.01)[3].
作用机制 The carboxamide amine moiety forms hydrogen bonds with the side-chain carbonyl group of Gln859 and possibly the backbone carbonyl group of Ser854[3].

A66 参考文献

[1]Jamieson S, Flanagan JU, et al. A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types. Biochem J. 2011 Aug 15;438(1):53-62.

[2]Sun M, Hillmann P, et al. Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha. Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15547-52.

[3]A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types

A66 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.54mL

0.51mL

0.25mL

12.71mL

2.54mL

1.27mL

25.41mL

5.08mL

2.54mL

A66 技术信息

CAS号1166227-08-2
分子式C17H23N5O2S2
分子量 393.527
别名
运输蓝冰
存储条件

粉末 Sealed in dry,Store in freezer, under -20°C

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 50 mg/mL(127.06 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。